Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 27, 2013 09:19 ET | Source: Acasti Pharma Inc.

Acasti Announces Pricing of US$20 Million Offering of Units

LAVAL, Quebec, Nov. 27, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research,...
November 26, 2013 16:01 ET | Source: Acasti Pharma Inc.

Acasti Announces Proposed Offering of Units

LAVAL, Quebec, Nov. 26, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research,...
November 11, 2013 08:30 ET | Source: Acasti Pharma Inc.

Acasti Completes PK IND Submission

LAVAL, Quebec, Nov. 11, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), a subsidiary of Neptune Technologies & Bioressources Inc., announces that...
November 05, 2013 08:30 ET | Source: Acasti Pharma Inc.

Reed V. Tuckson, M.D. Joins Acasti's Board of Directors

LAVAL, Quebec, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), a subsidiary of Neptune Technologies & Bioressources Inc., announces the...
October 29, 2013 08:30 ET | Source: Acasti Pharma Inc.

Acasti Strengthens Its IP Portfolio

LAVAL, Quebec, Oct. 29, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti") (Nasdaq:ACST) (TSX‑V:APO), a Neptune Technologies & Bioressources Inc.'s ("Neptune") subsidiary, announces that the...
October 15, 2013 08:00 ET | Source: Acasti Pharma Inc.

Acasti Announces Second Quarter Results

LAVAL, Quebec, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies & Bioressources Inc.'s ("Neptune") subsidiary,...
August 13, 2013 08:40 ET | Source: Acasti Pharma Inc.

Acasti Announces Positive Phase II Open Label Clinical Trial Results

LAVAL, Quebec, Aug. 13, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies & Bioressources Inc.'s ("Neptune") subsidiary,...
July 31, 2013 08:00 ET | Source: Acasti Pharma Inc.

Acasti Signs Manufacturing Agreement

LAVAL, Quebec, July 31, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies & Bioressources Inc.'s ("Neptune") subsidiary,...
July 15, 2013 08:00 ET | Source: Acasti Pharma Inc.

Acasti Announces First Quarter Results

LAVAL, Quebec, July 15, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies & Bioressources Inc.'s ("Neptune") subsidiary,...
June 28, 2013 08:00 ET | Source: Acasti Pharma Inc.

Acasti Reports Results of Annual and Special Meeting

LAVAL, Quebec, June 28, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies & Bioressources Inc.'s ("Neptune") subsidiary,...